Janney Montgomery Scott’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-30,000
| Closed | -$29K | – | 2680 |
|
|
2024
Q3 | $29K | Hold |
30,000
| – | – | ﹤0.01% | 2630 |
|
|
2024
Q2 | $29K | Hold |
30,000
| – | – | ﹤0.01% | 2572 |
|
|
2024
Q1 | $47K | Hold |
30,000
| – | – | ﹤0.01% | 2681 |
|
|
2023
Q4 | $24K | Hold |
30,000
| – | – | ﹤0.01% | 2604 |
|
|
2023
Q3 | $23K | Hold |
30,000
| – | – | ﹤0.01% | 2532 |
|
|
2023
Q2 | $28K | Hold |
30,000
| – | – | ﹤0.01% | 2608 |
|
|
2023
Q1 | $33K | Hold |
30,000
| – | – | ﹤0.01% | 2424 |
|
|
2022
Q4 | $44K | Hold |
30,000
| – | – | ﹤0.01% | 2518 |
|
|
2022
Q3 | $32K | Hold |
30,000
| – | – | ﹤0.01% | 2465 |
|
|
2022
Q2 | $52K | Hold |
30,000
| – | – | ﹤0.01% | 2283 |
|
|
2022
Q1 | $62K | Hold |
30,000
| – | – | ﹤0.01% | 2205 |
|
|
2021
Q4 | $112K | Hold |
30,000
| – | – | ﹤0.01% | 2303 |
|
|
2021
Q3 | $155K | Hold |
30,000
| – | – | ﹤0.01% | 2197 |
|
|
2021
Q2 | $128K | Hold |
30,000
| – | – | ﹤0.01% | 2192 |
|
|
2021
Q1 | $159K | Buy |
+30,000
| New | +$159K | ﹤0.01% | 2086 |
|